Search results for "retinal vein occlusion"

showing 10 items of 33 documents

Cumulative visual impact of two coagulability disorders: A case report.

2020

Cumulative visual impact of two coagulability disorders were reviewed by presenting a case of a young female patient with a spontaneous abortion and two thromboembolic events in 8 years, whose visual function was severely affected. The particularities of her genetic constellation regarding the retinal circulation are also discussed. The patient developed a central retinal artery occlusion in the right eye during pregnancy in 2010, which led to an extended hematological workup that revealed presence of MTHFR C677T and MTHFR A1298C heterozygote mutations. The screening for myeloproliferative disorders showed JAK2 V617F gene mutation. Test results confirmed the diagnosis of thrombophilia and e…

0301 basic medicineCancer Researchmedicine.medical_specialtyVisual acuitygenetic structuresRetinal ArteryGene mutationThrombophilia03 medical and health sciences0302 clinical medicineImmunology and Microbiology (miscellaneous)Central retinal vein occlusionInternal medicinemedicinepapillophlebitiscoagulationVeincentral retinal artery occlusionthrombophiliaessential thrombocythemiabusiness.industrycentral retinal vein occlusionGeneral MedicineArticlesmedicine.diseaseThrombosiseye diseases030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisCardiologyCentral retinal artery occlusionmedicine.symptombusinessExperimental and therapeutic medicine
researchProduct

Widening use of dexamethasone implant for the treatment of macular edema

2017

Vincenza Bonfiglio, Michele Reibaldi, Matteo Fallico, Andrea Russo, Alessandra Pizzo, Stefano Fichera, Carlo Rapisarda, Iacopo Macchi, Teresio Avitabile, Antonio Longo Department of Ophthalmology, University of Catania, Catania, Italy Abstract: Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is formulated in a biodegradable copolymer to release the active ingredient within the vitreous chamber for up to 6 months after an intravitreal injection, allowing a prolonged interval of effica…

3003intravitrealgenetic structuresimplantmedicine.medical_treatmentPharmaceutical ScienceVitrectomyReviewDrug Implantcorticosteroids0302 clinical medicineGlucocorticoidCentral retinal vein occlusionDrug DiscoveryDelayed-Action PreparationCorticosteroidRandomized Controlled Trials as TopicDrug ImplantsCorticosteroids; Dexamethasone; Implant; Intravitreal; Macular edema; Pharmacology; 3003; Drug Discovery3003 Pharmaceutical ScienceDiabetic retinopathyIntravitreal InjectionsUveitismedicine.drugHumanmedicine.medical_specialtydexamethasone03 medical and health sciencesOphthalmologymedicineHumansMacular edemaGlucocorticoidsDexamethasonePharmacologyMacular edemaDiabetic Retinopathybusiness.industryIntravitreal InjectionDrug Discovery3003 Pharmaceutical Sciencelcsh:RM1-950Macular degenerationmedicine.diseaseeye diseasesSurgerylcsh:Therapeutics. PharmacologyDelayed-Action Preparations030221 ophthalmology & optometryBranch retinal vein occlusionsense organsbusiness030217 neurology & neurosurgeryDrug Design, Development and Therapy
researchProduct

Experimental Percutaneous Cannulation of the Supraorbital Arteries: Implication for Future Therapy

2005

Purpose There is some evidence to suggest that thrombolysis has a beneficial effect in retinal vessel occlusion. However, there is concern that this therapeutic approach carries the risk of hemorrhage. Retrograde cannulation of the supraorbital arteries followed by irrigation with fibrinolytic agents may have the potential to minimize the risk of major complications. The study was conducted to investigate the anatomic and sonographic features of the supraorbital arteries. Methods This cadaver dissection study was performed on the orbits of 12 cadaveric specimens. In each orbit, the supraorbital region was dissected, followed by cannulation of the supraorbital vessels and injection of ink. I…

AdultMalePercutaneousSupratrochlear arteryDissection (medical)Ophthalmic ArteryCadavermedicine.arteryCatheterization PeripheralRetinal Vein OcclusionOcclusionmedicineHumansThrombolytic Therapybusiness.industryUltrasonography DopplerArteriesAnatomySupraorbital arterymedicine.diseaseCarbonmedicine.anatomical_structureFemalebusinessOrbitFibrinolytic agentOrbit (anatomy)Investigative Opthalmology & Visual Science
researchProduct

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial

2014

Purpose To compare standard-of-care grid laser photocoagulation versus intravitreal ranibizumab (IVR) versus a combination of both in the treatment of chronic (>3 months) macular oedema secondary to branch retinal vein occlusion. Methods Prospective, randomized, multicentre clinical trial. Thirty patients with a best-corrected visual acuity (BCVA) between 20/320 and 20/40 were randomized 1:1:1 to receive grid laser or three monthly injections of 0.5 mg IVR or both followed by 3 months of observation. Results Mean change from baseline BCVA at month 6 was +2 letters [laser; 0.04 logMAR, 95% confidence interval (−0.17; 0.25)], +17 letters [IVR; 0.34 (0.19; 0.5)] and +6 letters [combination; 0.…

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyVisual acuitygenetic structuresVisual AcuityAngiogenesis InhibitorsAntibodies Monoclonal HumanizedMacular Edemalaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled trialRecurrencelawRanibizumabOphthalmologyRetinal Vein OcclusionHumansMedicineProspective Studies030212 general & internal medicineMacular edemaAgedAged 80 and overLaser Coagulationbusiness.industryRetinalGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyConfidence interval3. Good healthSurgeryClinical trialOphthalmologychemistryIntravitreal Injections030221 ophthalmology & optometryBranch retinal vein occlusionFemaleLasers SemiconductorRanibizumabmedicine.symptombusinessmedicine.drugActa Ophthalmologica
researchProduct

Risk factors associated with retinal vein occlusion

2014

Summary Aims Retinal vein occlusion (RVO) is the most frequent retinal vascular disease after diabetic retinopathy in which arterial risk factors are much more relevant than venous factors. The objective was to evaluate the role of risk factors in the development of the first episode of RVO. Subjects and Methods One hundred patients with RVO [mean age 56 years, 42% females and mean body mass index (BMI) 27.5 kg/m2] were recruited consecutively from the outpatient clinic of a tertiary hospital in Valencia (Spain). All subjects underwent clinical assessment including anthropometric and blood pressure measurements and laboratory test including homocysteine, antiphospholipid antibodies (aPLAs) …

AdultMalemedicine.medical_specialtyPopulationThrombophiliaRisk FactorsInternal medicineRetinal Vein OcclusionPrevalencemedicineHumansThrombophiliaOutpatient clinicObesityeducationAgedDyslipidemiasFirst episodeeducation.field_of_studybusiness.industryVascular diseaseCarotid ultrasonographyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryBlood pressureSpainHypertensionCohortFemalebusinessInternational Journal of Clinical Practice
researchProduct

Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study.

2015

SummaryObjective To determine the age- and sex-specific prevalence and determinants of retinal vein occlusions (RVOs) in a large population-based German cohort. Methods The investigation included 15 010 participants (aged 35–74 years) from the Gutenberg Health Study. We determined the prevalence of RVO (central retinal vein occlusion [CRVO] and branch retinal vein occlusion [BRVO]) for the local population by assessing fundus photographs of 12 954 (86.3%; 49.8% women and 50.2% men) participants. Further, we analyzed the associations of RVO with cardiovascular, anthropometric, and ophthalmic parameters. Results The weighted prevalences of RVO, CRVO, and BRVO were 0.40%, 0.08%, and 0.32%, res…

AdultMalemedicine.medical_specialtyPopulationVision DisordersVisual AcuitySex FactorsCentral retinal vein occlusionRisk FactorsInternal medicineGermanyAtrial FibrillationRetinal Vein OcclusionmedicineOdds RatioPrevalenceHumansRisk factorFamily historyeducationStrokeAgededucation.field_of_studybusiness.industryAge FactorsHematologyOdds ratioMiddle Agedmedicine.diseaseeye diseasesSurgeryStrokeLogistic ModelsPhenotypeCohortHypertensionBranch retinal vein occlusionFemalebusinessJournal of thrombosis and haemostasis : JTH
researchProduct

Retinal vascular occlusion and deficiencies in the protein C pathway.

1999

Abstract PURPOSE: To report abnormalities in the protein C pathway and other vascular occlusion risk factors in patients with retinal vascular occlusion. METHODS: In a study, we investigated 76 consecutive patients who had in-patient evaluation of venous or arterial retinal vascular occlusion. All patients underwent comprehensive tests for coagulation disorders including determinations of protein C, protein S, lupus anticoagulants, and resistance to activated protein C and were screened for vascular disease risk factors. Resistance to activated protein C was confirmed by a polymerase chain reaction method to detect the specific factor V R506Q mutation. For comparative purposes, we also scre…

AdultMalemedicine.medical_specialtyRetinal Artery OcclusionDeep veinVascular occlusionGastroenterologyProtein SProtein SCentral retinal vein occlusionRisk FactorsInternal medicineRetinal Vein OcclusionmedicinePrevalenceHumansProspective StudiesActivated Protein C ResistanceAgedRetinal Vascular OcclusionAged 80 and overbiologybusiness.industryFactor VFactor VProtein C DeficiencyMiddle Agedmedicine.diseaseThrombosisSurgeryOphthalmologymedicine.anatomical_structureLupus Coagulation InhibitorMutationbiology.proteinBranch retinal vein occlusionFemalemedicine.symptombusinessProtein CAmerican journal of ophthalmology
researchProduct

Central retinal vein occlusion in young people.

1992

In a study performed on 20 subjects with central retinal vein occlusion (CRVO) aged 40 years or less we found the ischemic form in 20%. Disc edema was a common finding at the onset, while macular edema was less frequently seen. Systemic or ocular disorders that could be related with the development of the CRVO were often found; a patient was affected with myasthenia gravis and another with Sturge-Weber syndrome: these two diseases were not previously reported in association with CRVO. In only two of the 11 patients followed-up the visual acuity improved. The visual prognosis in CRVO of young people is often poor; the more frequent cause of the reduced visual acuity is chronic cystoid macula…

AdultMalemedicine.medical_specialtyVisual acuitygenetic structuresAdolescentEye diseaseIschemiaVisual AcuityCentral retinal vein occlusionIschemiaPhysiology (medical)OphthalmologyEdemaRetinal Vein OcclusionmedicineHumansYoung adultMacular edemabusiness.industrymedicine.diseasePrognosiseye diseasesSensory SystemsSurgeryOphthalmologyFemalesense organsmedicine.symptombusinessRetinopathyFollow-Up StudiesDocumenta ophthalmologica. Advances in ophthalmology
researchProduct

Cilioretinal artery occlusion.

2015

Background: The aim of this study was to evaluate characteristic findings and functional outcome of this rare type of retinal vascular occlusion in a large patient series. Patients and Methods: A retrospective chart review of all patients with a cilioretinal artery obstruction (CAO) seen at the University Eye Clinic Mainz (Germany) over a ten-year period between 1/1999 and 12/2008 was undertaken. The mean follow-up amounted to 42 months. Results: Thirty-three eyes were diagnosed with CAO. Three distinct groups were differentiated: (i) isolated CAO in 20/33 eyes; visual outcome achieving 20/50 in 17/20 eyes; (ii) CAO combined with central retinal vein occlusion in 9/33 eyes; visual outcome a…

AdultMalemedicine.medical_specialtygenetic structuresRetinal Artery OcclusionRetinal Artery OcclusionVision DisordersVisual AcuityDiagnosis DifferentialCentral retinal vein occlusionAnterior ischaemic optic neuropathyChart reviewRetinal Vein OcclusionmedicineHumansOptic Neuropathy IschemicAgedRetinal Vascular OcclusionAged 80 and overbusiness.industryMiddle Agedmedicine.diseaseeye diseasesSurgeryOphthalmologyCilioretinal artery occlusionCilioretinal arteryFemalesense organsbusinessKlinische Monatsblatter fur Augenheilkunde
researchProduct

Macular edema computer-aided evaluation in ocular vein occlusions.

1998

This paper is concerned with the use of digital fundus imaging to detect, quantify, and follow up macular angiographic leakage due to retinal vein occlusions. Images were matched automatically. We detected those pixels with a high increment in gray level within the closest area to the foveal center. Binary images displaying leakage were obtained. The procedure was checked against two observers' agreement. Twenty-one angiographic studies were collected. Two images of each sequence were selected for digitalization. Numerical descriptors of the leakage were proposed and quantification plots were designed for each pair of images. Interobserver concordance ranged between 82 and 98% when manually…

Adultmedicine.medical_specialtyComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONMedicine (miscellaneous)Capillary PermeabilityFovealOcclusionRetinal Vein OcclusionmedicineEdemaHumansMacula LuteaDiagnosis Computer-AssistedFluorescein AngiographyMacular edemaObserver VariationPixelmedicine.diagnostic_testbusiness.industryBinary imagemedicine.diseaseFluorescein angiographyPrognosisEvaluation Studies as TopicMaculopathyFemaleRadiologybusinessRetinopathyComputers and biomedical research, an international journal
researchProduct